◆ 会议时间:2026年9月1-4日
◆ 会议地点:加拿大 多伦多
◆ 会议简介:
2026年第29届国际肥胖与代谢病外科联盟(IFSO)世界大会将于2026年9月1-4日日在加拿大多伦多举行。IFSO世界大会是全球最具影响力的肥胖症会议之一,将为与会者提供一个交流重度肥胖患者外科治疗方面的知识,展示新的技术、研究和概念,并与该领域专家会面的平台,最终目的是教育人们预防肥胖和代谢紊乱。
国际肥胖与代谢病外科联盟(IFSO)是由63个官方国家肥胖外科医师协会和个人成员组成的联盟。IFSO的使命是统一全球的科学、外科和综合卫生团体,以传播知识、合作和建立以治疗基于肥胖症的慢性病患者的通用护理标准。IFSO的主要目标宣是联合外科医生和相关医护人员以优化重度肥胖患者的治疗,IFSO致力于建立一个全球性的肥胖治疗中心和外科医师认证体系(未经本站许可,禁止复制摘录镜像本站任何内容-领域国际医学会议网(lingyuint.com) 。
IFSO 2026 - The 29th World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
Date:
1-4 September 2026
Venue:
Toronto, Ontario, Canada
摘要征文投稿:
Abstract submissions
Abstract Submission Opens
Mid - September, 2025
Abstract Submission Deadline
6 January, 2026
Abstract Submission Notifications
End - February, 2026
点此提交摘要>>>Submit Abstract>>>
Presentation Types
Submissions will be accepted for the following presentation types:
-
Oral Presentation
- Using PowerPoint slides
- Presented by one nominated author
- Presentations will include two (2) minutes each for audience questions.
-
ePoster
- Authors will have the opportunity to have their ePoster displayed on screens for delegates to view for the entire duration of the Congress. ePosters provide visual display of new techniques, programs, research or professional innovations. They are the ideal medium for the presentation of complex visual material and emerging practice content.
-
Video
- The maximum length of the video is 7 minutes. Instructions for preparation can be found in the guidelines below.
Abstract Content
All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university-specific publications office (or another similar facility), or by a copy editor prior to submission.
The author is responsible for the accuracy of the abstract.
- Abstract title – must be in UPPER CASE and limited to 20 words. Please submit symbols as words.
- Abstract text – limited to 350 words, including acknowledgments. (Please Note: word count is affected when graphs/tables are included). Abstracts must contain original scientific data collected by the author(s). Do not include references in your abstract body.
- Abstract topic – select the abstract topic per the list of topics.
- Tables – a maximum of 2 tables can be incorporated and placed anywhere in the abstract.
- Images – The abstract can incorporate a maximum of 2 images. Each image’s maximum file size is 500 KB, and the graph/image’s maximum pixel size is 600(w) x 800(h) pixels. You may upload images in JPG, GIF, or PNG format. Note that images don’t affect the word count.
- Abstract Format – Abstracts need to be structured under the following sub-headings. The abstract should not repeat the title, authors and affiliations
Background
Objectives
Methods
Results
Conclusion
- Use only standard abbreviations. Special or unusual abbreviations should be placed in parentheses after the full word the first time they appear.
- Use generic names of drugs. If you have any commercial interests or associations that might pose a conflict of interest regarding the submission, they must be declared. If accepted for presentation, the commercial interest or association must be declared on the title slide or the slide immediately following the title slide.
- Submissions may not contain patient names, hospital ID numbers, or other identifying information.
- The submission form allows you to store your abstract as a draft until the deadline. If not submitted by the deadline, drafts will be deleted.
- Click the SUBMIT button at the end of the process to save your abstract. You may log in to the system later to make changes to your abstract up to the submission deadline. After the deadline, abstracts cannot be modified or corrected.
- After you submit your abstract, you will receive an abstract ID number via email. Please refer to this abstract number in all correspondence regarding the abstract.
- Please email us IFSOEC26_Abstracts@kenes.com if you have not received confirmation that your abstract has been submitted.
- Please do not submit multiple copies of the same abstract.
Dear Colleagues and IFSO Members,
It is our great pleasure to welcome you to the XXIX IFSO World Congress 2026 in Toronto, Ontario, Canada.
This year’s theme, “The Future of Obesity Management: From Weight Loss to Health Gain” highlights a pivotal shift in managing metabolic conditions, from a focus on weight reduction toward comprehensive health improvement and the effective resolution of comorbidities.
The Congress will unite global leaders from diverse disciplines, including bariatric and metabolic surgeons, medical specialists, allied healthcare providers, researchers, and industry innovators, to redefine best practices in medical and surgical treatments, ultimately improving patient outcomes and enhancing quality of life.
Set against Toronto’s dynamic and multicultural backdrop, the Congress offers attendees the opportunity to experience iconic landmarks such as the CN Tower, the beautiful waterfront, culturally rich neighborhoods, and internationally renowned museums and galleries. We warmly invite you to actively participate in engaging scientific sessions, innovative workshops, interactive pre-congress courses, and valuable networking opportunities.
Together, let’s embrace this transformative approach to bariatric care—one that transcends weight loss, aiming instead for meaningful and lifelong patient wellness.
We look forward to welcoming you to Toronto as we collectively shape the future of metabolic healthcare.
Mehran Anvari
IFSO Congress President
Khaled Gawdat
IFSO President
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|